Accession Therapeutics Limited
0 followers
‌
Accession Therapeutics’ elegant Trocept platform has potential to treat some of the most intractable and widespread forms of cancer. Based in Oxford, UK, it is developing a pipeline of products to the early clinical trial stage. Led by Bent Jakobsen, PhD FMedSci, a pioneer of T cell receptor therapy... Read more
Industries
Headquarters
Employees
Links
Org chart
Bent Jakobsen
Founder and CEO
Bent Jakobsen
Collapse
Alan Parker
Founder And Chief Scientific Officer - Trocept Therapeutics
Andy Johnson
Head of CMC
Jez (Andrew) Gerry
Chief Operating Officer
Johanne Pentier, Ph. D.
Associate director - Portfolio manager
Lok Hang Mak
Associate Director
Rita Figueiredo
Associate Director of Antigen Recognition
Tony Hinton
IT Manager
Stephanie Smith Bewick
Chief Business Officer
